About
Stem Cell Technology
Areas of Focus
Categories
Non-PharmaceuticalBiotech
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
203
By Phase
PHASE3: 1PHASE2: 1PHASE2/PHASE3: 1
By Status
TERMINATED: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT03775421Collaborator
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
PHASE3Terminated
112 participants
Started: Apr 11, 2019 · Completed: Jan 18, 2022
NCT03714815Collaborator
A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
PHASE2Terminated
91 participants
Started: Dec 7, 2018 · Completed: Oct 12, 2021
NCT01790763Collaborator
Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds
PHASE2/PHASE3Withdrawn
Started: Apr 30, 2015 · Completed: Apr 30, 2015
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...